Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04140292 · ClinicalTrials.gov registry record · Phase 2
Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses
A Phase 2 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
NCT04140292 is a Phase 2 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 75 participants.
The verdict
NCT04140292, a Phase 2 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
Study Summary
This study is open to individuals with Actinic Keratoses (skin lesions that have the potential to turn into skin cancer), who are receiving photodynamic therapy (PDT) as part of their clinical care. The purpose of this study is to test and demonstrate that vitamin D pre-treatment can enhance PDT efficacy in the treatment of Actinic Keratoses. Participants will be asked to take vitamin D supplements prior to their standard of care PDT treatment. Participation in the research will last about 3-4 months.
Interventions
- DRUG Vitamin D3
- DRUG Photodynamic therapy (PDT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-01-13 |
| Est. Completion | 2021-05-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04140292
The ClinicalTrials.gov registry entry for NCT04140292 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 is the first listed.
NCT04140292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04140292 about?
NCT04140292 is a clinical study titled "Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses". This study is open to individuals with Actinic Keratoses (skin lesions that have the potential to turn into skin cancer), who are receiving photodynamic therapy (PDT) as part of their clinical care. The purpose of this study is to test and demonstrate that vitamin D pre-treatment can enhance PDT eff...
What is the current status of trial NCT04140292?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2020-01-13. Estimated completion is 2021-05-27.
What interventions are being tested in trial NCT04140292?
The interventions under investigation include: Vitamin D3 (DRUG), Photodynamic therapy (PDT) (DRUG).
Who is sponsoring clinical trial NCT04140292?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.